Summary Rice et al. (1986) have described a flow cytometric method where the non-fluorescent probe monochlorobimane (mBCl) forms a fluorescent adduct with cellular glutathione (GSH) under the action of glutathione-S-transferase. We show here that for EMT6 carcinosarcoma cells there is a close correlation between mean cell fluorescence, expressed as a ratio to that of fluorescence calibration beads, and biochemically determined GSH content over the range 0.2 -2.0 fmol cell' . Single cell suspensions from 14 human cancers were prepared by 23-gauge needle aspiration or mechanical disaggregation of surgical specimens, stained using mBCI and examined by flow cytometry. There was a wide range in individual cell fluorescence, which in contrast to EMT6 cells was not strongly correlated with (Ozols et al., 1987; Lee et al., 1987; Skapek et al., 1988 Clinical samples A total of 14 clinical samples were examined. Seven of these were obtained by 23 gauge needle aspiration from patients who gave verbal informed consent for the procedure, one consisted of peripheral blood lymphoblasts separated by density-gradient centrifugation from a patient with end-stage T-cell acute lymphoblastic leukaemia, and the remainder were fresh surgical specimens which were mechanically disaggregated using crossed scalpel blades. Cell suspensions were filtered through gauze, washed and counted. If necessary, clumps were dispersed by syringing through 25 gauge needles. After adjusting to a final concentration of I x 106ml-', cells were filtered through 70 tm plankton netting and stained using 40 JiM mBCI for exactly 5 min at 2O°C. Flow cytometry was done exactly as for cultured cells, except that the machine was triggered on Coulter volume, set at a threshold level of 300 jtm3 to exclude red blood cells and cellular debris. In addition to fluorescence, the ratio of cell fluorescence to Coulter volume was obtained using the electronics of the FACS Analyser.
lonising radiation and a variety of clinically useful cytotoxic drugs produce reactive free radicals capable of interacting with essential cellular macromolecules, particularly DNA. The ubiquitous sulphydryl-containing tripeptide glutathione can protect from this damage by scavenging free radicals, either spontaneously or when catalysed by one of the glutathione-S-transferase isoenzymes. It can in addition reduce hydrogen peroxide or disulphide bonds by undergoing an oxidation/reduction cycle under the actions of glutathione peroxidase and glutathione reductase (Meister & Anderson, 1983) . Glutathione is an abundant molecule in cells, cytoplasmic concentrations being typically in the millimolar range, and there is increasing evidence that elevated tumour cell GSH or glutathione-S-transferase activity could be an important cause of radiation and alkylating agent resistance in cancer patients. In particular, resistant cell lines often show an elevated GSH content, while pre-treatment of tumourbearing animals with buthionine sulphoximine (BSO), which reduces GSH content by blocking gamma-glutamyl-cysteine synthetase, can improve the therapeutic index of alkylating agents (Ozols et al., 1987; Lee et al., 1987; Skapek et al., 1988 Tietze (1969) . This involves reduction of the aromatic disulphide 5,5'-dithiobis(2-nitrobenzoic acid) (DTNB) to the chromogenic TNB by GSH, which is oxidised to its disulphide-linked dimeric form GSSG. In order to maintain the reaction, GSSG is reduced back to GSH by addition of glutathione reductase and NADPH. After equilibration at room temperature the reaction was started by the addition of glutathione reductase, and the linear increase in absorbence at 412nm seen using the test sample compared to that obtained using a standard containing reduced GSH. Results were expressed as fmol GSH per cell. (Figure 3) . Indeed, in many cases those cells C.A. Breast-FNAB with the greatest volume showed only weak fluorescence, indicating that this wide range of values was not due to the presence of cell clumps. Restaining the sample illustrated in Figure 3 for cellular DNA content showed that approximately 90% of the cells were aneuploid, i.e. there was minimal contamination with normal host cells.
The relative fluorescence of the calibration beads was recorded immediately before running each of the clinical samples, and because these were stained under identical conditions to the EMT6 cells, the relationship between fluorescence and GSH content shown in Figure 2 was used to approximate mean GSH content of the tumour biopsies. This gave a mean value of 0.21 ± 0.12 fmol cell-' for the lymphomas, and 0.95 ± 0.39 for the solid tumours. Scatter of mean values is shown in Figure 4 . Note that all samples were well within the linear part of the fluorescence/GSH content plot for EMT6 cells.
Discussion
The ubiquitous presence of large amounts of GSH in cells reflects the need to detoxify free radicals generated by, for example, incomplete reduction of molecular oxygen or by certain xenobiotics. Because many anti-cancer agents mimic the actions of these natural threats to cells, it is not surprising that GSH and its related enzymes are implicated in clinical drug or radiation resistance. Interestingly, there is now evidence linking increased GSH-S-transferase or GSH peroxidase activities to enhanced mdr gene expression (Kramer et al., 1988) , and to capacity for DNA repair (Deffie et al., 1988) , suggesting that multifactorial cancer cell resistance could simply be the recruitment of a multi-layer defence system which evolved to protect macromolecules from common environmental hazards.
Despite an extensive literature examining the role of GSH in drug or radiation resistance in experimental model systems, surprisingly little has been published concerning fresh human cancer specimens. It would be important to determine the extent to which tumour cell GSH content caused clinical drug or radiation resistance, because methods for overcoming this have been proposed. In particular, GSH depletion using BSO can improve the therapeutic index of alkylating agents used to treat human tumour xenografts, and phase 1 trials of BSO in cancer patients are underway. Measurement of GSH using mBCl is an unusual FCM method, because its specificity depends on GSH-S-transferase combining it to GSH rather than to other sulphydryls. Recent evidence (Cook et al., 1989) would suggest in fact that for at least some cell lines this, rather than GSH content, determines mBCI fluorescence. Cellular GSH turns over quite rapidly, and GSH feedback inhibits its own synthesis. Following reaction with an electrophile, GSH can be degraded, and its constituent amino acids recycled (Meister & Anderson, 1983) . The complex time and concentration dependence of EMT6 cells illustrated in Figure 1 probably reflects these processes, since the act of staining cells with mBCl would be expected to cause depletion of target molecule. The higher concentrations of mBCI used exceed the total GSH content of the cell sample by several fold, and might therefore stimulate resynthesis as they deplete cells of existing GSH. Rice et al. (1986) showed that following its depletion by diethylmaleate, GSH content of EMT6 cells approximately doubled every 60 min. In contrast, the lower concentrations of mBCI might become exhausted as the GSH-mBCl adduct is degraded. It seems possible therefore that the assay is giving an overall picture of a cell's ability to cope with a reactive chemical species rather than simply measuring GSH. A more detailed picture of the processes involved might be obtained by the additional use of other sulphydryl stains such as mercury orange (O'Connor et al., 1988) , which, although probably less specific for GSH, stains non-enzymatically at 4°C. Despite the fact that an unusual dependence on a number of enzymes means that equilibrium between fluorochrome and target molecule is probably never achieved, EMT6 cells stained for 5 min using 40 ILM mBCI had a mean fluorescence which correlated closely with biochemically determined GSH content over the range 0.2--2.0 fmol cell-'. We 
